Implications of cardiovascular comorbidity and serum proadrenomedullin in dyspnoea scores in stable COPD
D. Stolz, K. Kostantinos, F. Blasi, J. Rakic, P. Castellotti, B. Milenkovic, W. Boersma, A. Lacoma, C. Prat, T. Welte, R. Louis, J. Aerts, A. Torres, E. Wouters, M. Tamm (Basel, Switzerland; Larissa, Greece; Milan, Italy; Belgrade, Republic Of Serbia; Breda, Maastricht, Netherlands; Badalona, Barcelona, Spain; Hannover, Germany; Liege, Belgium)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Session: COPD: cardiovascular comorbidities
Session type: E-Communication Session
Number: 5215
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Stolz, K. Kostantinos, F. Blasi, J. Rakic, P. Castellotti, B. Milenkovic, W. Boersma, A. Lacoma, C. Prat, T. Welte, R. Louis, J. Aerts, A. Torres, E. Wouters, M. Tamm (Basel, Switzerland; Larissa, Greece; Milan, Italy; Belgrade, Republic Of Serbia; Breda, Maastricht, Netherlands; Badalona, Barcelona, Spain; Hannover, Germany; Liege, Belgium). Implications of cardiovascular comorbidity and serum proadrenomedullin in dyspnoea scores in stable COPD. Eur Respir J 2010; 36: Suppl. 54, 5215
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: